| Financial Year |
March 31 2023 |
| Monetary Funds |
1,165,866,971.44 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
49,129,017.78 |
| Advances to Suppliers |
138,504,032.60 |
| Other Receivables |
40,168,621.76 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
3,957,026,751.59 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
264,677,697.81 |
| Total Current Assets |
5,615,373,092.98 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
706,361,465.94 |
| Investment Properties |
45,965,700.00 |
| Fixed Assetes |
3,581,171.91 |
| Under-construction Projects |
166,197,542.83 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
3,320,462.82 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
72,660.35 |
| Deferred Income Tax Assets |
32,629,755.01 |
| Other Non-Current Assets |
1,660,377.28 |
| Sub-Total of Non-Current Assets |
1,033,323,106.78 |
| Total Assets |
6,648,696,199.76 |
| Short-Term Loans |
11,927,364.99 |
| Trading Financial liabilities |
4,200,330.00 |
| Notes Payable |
-- |
| Accounts Payable |
614,089,699.44 |
| Accounts Received In Advance |
17,972,507.96 |
| Employee Compensation Payable |
5,336,828.28 |
| Taxes Payable |
537,737,996.87 |
| Interest Payable |
-- |
| Dividend Payable |
104,000.00 |
| Other payables |
47,559,905.84 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
136,662,978.91 |
| Sub-Total of Current Liabilities |
2,862,017,309.00 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
7,552,233.40 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
7,552,233.40 |
| Total Liabilities |
2,869,569,542.40 |
| Paid-In Capital(Or Share Stock) |
700,506,244.00 |
| Capital Surplus |
10,471,357.37 |
| Surplus Reserve |
297,364,156.36 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
2,756,790,635.45 |
| Minority Stockholder's Interest |
13,994,264.18 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,765,132,393.18 |
| Owner's Equity（Stockholder's Equity） |
3,779,126,657.36 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,648,696,199.76 |
